Endobronchial stent for malignant airway obstructions

Area of Science:

• Pulmonology
• Interventional Pulmonology
• Oncology

Background:

• Endobronchial stents are crucial for managing symptomatic airway obstructions, both benign and malignant.
• Malignant tracheobronchial narrowing presents significant challenges in patient care.

Purpose of the Study:

• To assess the safety and efficacy of airway stent placement for malignant tracheobronchial narrowing.
• To evaluate patient outcomes and complications associated with the procedure.

Main Methods:

• Retrospective review of patient records undergoing airway stent insertion for malignant disease (June 1995 - August 2004).
• Data collected included patient demographics, disease type, symptoms, treatment details, complications, and survival outcomes.
• Conscious sedation was the primary anesthetic method utilized.

Main Results:

• 37 stents were placed in 34 patients (ages 36-85) with primary lung cancer (35%) or metastatic disease (65%).
• Dyspnea was the most common symptom (82%). Stent placement under conscious sedation allowed early discharge for most patients (73%).
• 94% of patients experienced significant dyspnea relief, and 3 of 4 mechanically ventilated patients were weaned post-procedure. Median survival was 6 months.

Conclusions:

• Airway stent placement is a safe outpatient procedure using conscious sedation.
• The intervention provides significant symptomatic relief and has the potential to prolong survival in patients with malignant airway obstruction.